Wertpapierdatensatz · archiviertes Quartal
TERN
Terns Pharmaceuticals, Inc. · Healthcare · Biotechnology
16Erfasste Halter
0Δ Inhaber
30.56MGehaltene Aktien
$229.52MGemeldeter Wert
+0Neue Positionen
−0Ausstiege
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +1.5% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q1 2026 | 105 | +14 | 70.88M | $3.72B | +22 | −9 |
| Q4 2025 | 91 | +4 | 71.76M | $2.90B | +5 | — |
| Q3 2025 | 16 | 0 | 30.56M | $229.52M | — | — |
| Q2 2025 | 13 | 0 | 20.60M | $76.83M | +2 | −2 |
| Q1 2025 | 10 | -3 | 10.19M | $28.12M | — | −3 |
| Q4 2024 | 13 | +2 | 13.10M | $72.60M | +2 | — |
| Q3 2024 | 10 | -1 | 11.63M | $97.00M | — | −1 |
| Q2 2024 | 11 | — | 7.84M | $53.39M | — | — |
Wer es hält · Q3 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 7.59M | — | $56.99M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 7.59M | — | $56.99M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 7.59M | — | $56.99M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 7.59M | — | $56.99M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 7.59M | — | $56.99M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passiv) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passiv) | 4.56M | +5.9% | $34.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passiv) | 4.56M | +5.9% | $34.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passiv) | 4.56M | +5.9% | $34.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 3.94M | +207.7% | $29.58M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passiv) | 1.71M | +5.0% | $12.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passiv) | 1.71M | +5.0% | $12.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passiv) | 1.61M | +16.9% | $12.06M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 1.59M | -59.2% | $11.94M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Millennium Management ✦ | 941.58K | -5.5% | $7.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | Renaissance Technologies ✦ | 676.83K | -26.6% | $5.08M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | Goldman Sachs Group ✦ | 546.83K | — | $4.11M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Goldman Sachs Group ✦ | 546.83K | — | $4.11M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Wellington Management ✦ | 253.41K | -24.4% | $1.90M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 33 | Wellington Management ✦ | 253.41K | -24.4% | $1.90M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 34 | Wellington Management ✦ | 253.41K | -24.4% | $1.90M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | T. Rowe Price ✦ | 94.17K | +18.4% | $708,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 60.35K | +2.4% | $453,231 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 60.35K | +2.4% | $453,231 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 40.18K | +8.7% | $301,782 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 40.18K | +8.7% | $301,782 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 40.18K | +8.7% | $301,782 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 40.18K | +8.7% | $301,782 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 42 | Two Sigma Investments ✦ | 34.03K | -83.4% | $255,565 | 0.0% | ▼ Trim | 6 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 314 Inhaber, 121.84M Anteile, $6.09B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q3 2025 ·
Methodik ·
Über die API abrufen